| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 05/20/2008 | CA2415681C Pyrrolidine derivatives |
| 05/20/2008 | CA2305619C Novel glycosaminoglycan and pharmaceutical composition using the same as active ingredient |
| 05/20/2008 | CA2169621C Use of oligosaccharides for the prevention and treatment of tissue ageing |
| 05/15/2008 | WO2008058210A2 Local administration of gallium compositions to treat pain |
| 05/15/2008 | WO2008058098A2 Method of treating asthma, allergic rhinitis, and skin disorders |
| 05/15/2008 | WO2008058034A1 Methods of treating dermatological disorders or conditions |
| 05/15/2008 | WO2008057162A2 Native (telopeptide) placental collagen compositions |
| 05/15/2008 | WO2008056391A2 Composition for a pharmaceutical treatment based on triethyl citrate and adapalene |
| 05/15/2008 | WO2008056388A1 Drug based on ozonized terpenes or terpene-derivatives, processes for producing it and uses thereof |
| 05/15/2008 | WO2008056156A1 Salts of dihydroxyanthraquinone carboxylic acids and their therapeutic use |
| 05/15/2008 | WO2008056118A1 N-aryl-hydroxyalkylidene-carboxamide compounds and their use |
| 05/15/2008 | WO2008029306A3 Thiophene derivatives as s1p1/edg1 receptor agonists |
| 05/15/2008 | WO2008028192A3 Variable region sequences of il-31 monoclonal antibodies and methods of use |
| 05/15/2008 | US20080114075 2-(acetyloxy)-5-hydroxybenzenesulfonic acid, or 5-(acetyloxy)-2-hydroxybenzene-sulfonic acid, or 2,5-bis(acetyloxy)benzenesulfonic acid, or sultosilic acid for example; combination therapy with other drugs |
| 05/15/2008 | US20080114057 For therapy of dermatitis conditions and skin impairments such as atopic dermatitis, contact dermatitis, allergic contact dermatitis, allergic dermatitis, seborrheic dermatitis, nummular dermatitis, chronic dermatitis of hands or feet, generalized exfoliative dermatitis, stasis dermatitis |
| 05/15/2008 | US20080114031 1,2;5,6-Di-O-isopropylidene-3-deoxy-3-[{(4-chloro-phenyl)amino}-carbonyl]-amino- alpha -D-allofuranoside; |
| 05/15/2008 | US20080114025 Inhibiting a variety of pain, inflammation, spasm and restenosis processes resulting from cardiovascular or general vascular therapeutic and diagnostic procedures; use of ADP receptor antagonist and a thromboxane A2 receptor antagonist |
| 05/15/2008 | US20080114006 For example, 1-(5-(2-amino-8-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-6-yl)-2-fluorophenyl)-3-(3-tert-butyl-1-phenyl-1H-pyrazol-5-yl)urea; for treatment of mammalian cancers and inflammatory diseases including rheumatoid arthritis, retinopathies |
| 05/15/2008 | US20080114004 Hydrazone derivatives as kinase inhibitors |
| 05/15/2008 | US20080113997 Compounds, compositions, processes of making, and methods of use related to inhibiting macrophage migration inhibitory factor |
| 05/15/2008 | US20080113959 {Beta}-Lactamyl vasopression V1a antagonists and methods of use |
| 05/15/2008 | US20080113934 Administering formulation containing pyrimido-pyrimidine selected from dipyridamole, mopidamol in combination with an agent selected fromacetylsalicylic acid (ASA), clopidogrel, ticlopidine; strongly influencing the interaction of the vessel wall with the fibrin pathway of the coagulation system |
| 05/15/2008 | US20080113047 Herbal Composition for Tinea Infection |
| 05/15/2008 | US20080113037 Topical Compositions Comprising Polyhydroxy Acids and/or Lactones for Improved Cutaneous Effects of Oxidative Therapeutic Drugs |
| 05/15/2008 | US20080113033 Topical treatment and manufacturing method |
| 05/15/2008 | US20080113004 Gallium complex; pain, itching, allodynia, hyperalgesia, peripheral neuropathic pain associated with postherpetic neuralgia. |
| 05/15/2008 | US20080112921 Parenterally administering a combination of a abhesive nonionic polymer and a magnesium salt to a site of injury, e.g. polyoxyethylene glycol and magnesium chloride; blocking agents for for cellular adhesion and for methyl-D-asparate receptors; antiinflammatory agents; autoimmune diseases |
| 05/15/2008 | US20080112915 Skin disorders; metabolic disorders; gene therapy; biocompatability |
| 05/15/2008 | DE102006053500A1 Antimicrobial compounds for controlling selective microorganisms such as gram-positive bacteria, particularly coryneform bacteria, has general formula |
| 05/15/2008 | DE102006052755A1 New peptide derivatives and peptidomimetics are transglutaminase inhibitors useful for the treatment or prophylaxis of e.g. celiac disease, fibrosis, thrombosis, neurodegenerative disorders, Huntington's chorea and Parkinson disease |
| 05/15/2008 | CA2669038A1 Salts of dihydroxyanthraquinone carboxylic acids and their therapeutic use |
| 05/15/2008 | CA2668645A1 Method of treating asthma, allergic rhinitis, and skin disorders |
| 05/15/2008 | CA2668414A1 Methods of treating dermatological disorders or conditions |
| 05/15/2008 | CA2665369A1 Human placental collagen compositions, and methods of making and using the same |
| 05/14/2008 | EP1921133A2 System for processing lipoaspirate cells |
| 05/14/2008 | EP1921088A2 Peptides and related molecules that bind to tall-1 |
| 05/14/2008 | EP1921078A1 Multikinase inhibitor |
| 05/14/2008 | EP1919979A1 Polymer conjugates of k-252a and derivatives thereof |
| 05/14/2008 | EP1919500A2 Treatment of leg ulcers using placenta derived collagen biofabric |
| 05/14/2008 | EP1919480A2 Hedgehog pathway antagonists to treat disease |
| 05/14/2008 | EP1648566B1 Method for the production of flavonoid-containing compositions and use thereof |
| 05/14/2008 | EP1496875B1 Use of a mare's milk concentrate dried on a highly-dispersed, biologically inert matrix |
| 05/14/2008 | EP1235934B1 Screening method for candidate drugs |
| 05/14/2008 | EP1220948B1 Identification of a novel retrovirus associated with primary biliary cirrhosis and autoimmune disorders |
| 05/14/2008 | CN101180028A Use of adamantyl methoxydi phenyl propenoic acid for the treatment of acne |
| 05/14/2008 | CN101177438A N-acetylglucosamine derivatives and use thereof |
| 05/14/2008 | CN101176776A Medicament for curing flat wart |
| 05/14/2008 | CN101176763A Externally used medicament and preparation method thereof |
| 05/14/2008 | CN101176762A Lotion capable of neutralizing mosquito poison and relieving itching as well as detumescence |
| 05/14/2008 | CN101176758A Medicine for treating leucoderma and its preparation method |
| 05/14/2008 | CN101176754A Medicine composition for curing burns and scalds as well as method of making the same |
| 05/14/2008 | CN101176746A Pharmaceutical composition and uses thereof |
| 05/14/2008 | CN101176745A Method for making chinese medicine radix astragali |
| 05/14/2008 | CN100387597C Amide substituted imidazopyridines |
| 05/14/2008 | CN100387290C Ointment for curing fracture and preparation method |
| 05/14/2008 | CN100387289C Canine oil ointment for curing burn and stopping pain |
| 05/14/2008 | CN100387261C Medicnial liquid and technology for one step removing freckle, chloasma and senile plague |
| 05/14/2008 | CN100387249C Traditional Chinese medicine formulation for treating ulcer |
| 05/14/2008 | CN100387241C Chinese medicine for treating facial skin disease |
| 05/14/2008 | CN100387219C Pharmaceutical and cosmetic compositions against skin aging |
| 05/14/2008 | CA2610613A1 Antimicrobial compositions |
| 05/13/2008 | US7371895 antiinflammatory agents; autoimmune and cardiovascular disorders; atherosclerosis, rheumatoid arthritis, hyperlipemia; better water solubility increases the bioavailability and pharmacokinetics |
| 05/13/2008 | US7371819 Differs from nucleotide sequence of wild-type IFN alpha -17 gene, in that it comprises one or several SNPs (Single Nucleotide Polymorphism[s]); anticarcinogenic and antiproliferative agents; side effect reduction |
| 05/13/2008 | US7371779 Synergistic compositions of N-acylhomoserine lactones and 4-quinolones |
| 05/13/2008 | US7371765 Quinoline derivatives having VEGF inhibiting activity |
| 05/13/2008 | US7371754 Tyrosine kinase inhibitors |
| 05/13/2008 | US7371744 Photosensitizers for photodynamic therapy; killing tissue, cells; anticancer agents |
| 05/13/2008 | US7371740 Phosphorylated glyceryl ether aluminum salt |
| 05/13/2008 | US7371735 Inhibitor oligonucleotides and their use for specific repression of a gene |
| 05/13/2008 | US7371396 Dermatological and cosmetic compositions |
| 05/13/2008 | US7371383 Genetic enginieered mixtures of complementary determining regions(CDR) antigens used for analyzing neutralizing epitopes and for prophylaxis of allergies and respiratory system disorders |
| 05/13/2008 | US7371382 Grafting antibodies to nucleic acids; anticancer agents, osteoporosis, vision defects, antiinflammatory agents, skin disorders |
| 05/13/2008 | US7371377 Bone morpogenic proteins; endothelial growth factor e (vegfe); wound healing agents; tissue engineering; bradycardial agents |
| 05/13/2008 | US7371373 For diagnosis, prevention, or treatment of diseases responsive to therapy with interferon- beta; free of human serum albumin; stability |
| 05/13/2008 | CA2437814C Human monoclonal antibodies to fc alpha receptor (cd89) |
| 05/13/2008 | CA2410234C 5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl-[2,3']bipyridinyl in pure crystalline form and process for synthesis |
| 05/13/2008 | CA2344222C Adhesive protein foam for surgical and/or therapeutic uses |
| 05/13/2008 | CA2301717C Peptide with radio protective effect |
| 05/13/2008 | CA2279939C Treatment and prevention of adhesions |
| 05/13/2008 | CA2259780C Alcohol based anti-microbial compositions with cosmetic appearance |
| 05/13/2008 | CA2206119C Irrigation solution and method for inhibition of pain, inflammation and spasm |
| 05/08/2008 | WO2008054756A2 Sesquiterpene lactones from artemisia leucodes as anti-inflammatory and gene regulators |
| 05/08/2008 | WO2008054594A2 Method for controlling angiogenesis in animals |
| 05/08/2008 | WO2008053892A1 Pharmaceutical for promoting functional regeneration of damaged tissue |
| 05/08/2008 | WO2008053863A1 Novel compound having 1,4-benzothiazin-3-one skeleton or 3,4-dihydroquinolin-2-one skeleton |
| 05/08/2008 | WO2008053861A1 Novel compound having 1,4-benzoxazin-3-one skeleton |
| 05/08/2008 | WO2008053728A1 Agent for promoting healing of living body |
| 05/08/2008 | WO2008053246A1 Acne treatment |
| 05/08/2008 | WO2008052350A1 Photodynamic therapy for the treatment of hidradenitis suppurativa |
| 05/08/2008 | WO2008052326A1 Composition for the treatment of skin conditions |
| 05/08/2008 | WO2008052302A1 System and process for producing a low-suspended solids solution and uses therefore |
| 05/08/2008 | WO2008035982B1 COMBINATION OF A GLUCOCORTICOID AND A β-CYCLODEXTRIN CONJUGATED VITAMIN A DERIVATE COMPLEX |
| 05/08/2008 | WO2008034138A9 Methods and compositions for the topical oxygenation of hypoxic tissue |
| 05/08/2008 | WO2008015093A3 Textile material for management of skin health complications associated with skin folds, and its method of use |
| 05/08/2008 | WO2007017176A8 Wound-healing composition |
| 05/08/2008 | US20080108808 Dipeptidyl peptidase inhibitors |
| 05/08/2008 | US20080108807 Immunosuppressants; autoimmune disease; antiinflammatory agents; multiple sclerosis; rheumatic diseases; antiarthritic agents; aids; for example, 2-{6-[3-Amino-piperidin-1-yl]-3-ethyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl}-benzonitrile |
| 05/08/2008 | US20080108699 Composition Comprising Dihomo-y-Linolenic Acid (Dgla) As Active Ingredient |
| 05/08/2008 | US20080108681 Use of allantoin as a pro-collagen synthesis agent in cosmetic compositions |
| 05/08/2008 | US20080108628 Treatment of diseases or disorders mediated by T lymphocytes and/or PKC; may be coadminstered with an immunosuppressant, immunomodulatory, anti-inflammatory, antiproliferative or anti-diabetic drug |